91 research outputs found

    The Effect of Implant Length and Diameter on Stress Distribution around Single Implant Placement in 3D Posterior Mandibular FE Model Directly Constructed Form In Vivo CT

    Get PDF
    A three-dimensional (3D) finite element (FE) model of the mandibular bone was created from 3D X-ray CT scan images of a live human subject. Simulating the clinical situation of implant therapy at the mandibular first molar, virtual extraction of the tooth was performed at the 3D FE mandibular model, and 12 different implant diameters and lengths were virtually inserted in order to carry out a mechanical analysis. (1) High stress concentration was found at the surfaces of the buccal and lingual peri-implant bone adjacent to the sides of the neck in all the implants. (2) The greatest stress value was approximately 6.0 MPa with implant diameter of 3.8 mm, approx. 4.5 MPa with implant diameter of 4.3 mm, and approx. 3.2 MPa with implant diameter of 6.0 mm. (3) The stress on the peri-implant bone was found to decrease with increasing length and mainly in diameter of the implant

    Development of 3D CAD/FEM Analysis System for Natural Teeth and Jaw Bone Constructed from X-Ray CT Images

    Get PDF
    A three-dimensional finite element model of the lower first premolar, with the three layers of enamel, dentin, and pulp, and the mandible, with the two layers of cortical and cancellous bones, was directly constructed from noninvasively acquired CT images. This model was used to develop a system to analyze the stresses on the teeth and supporting bone structure during occlusion based on the finite element method and to examine the possibility of mechanical simulation

    Three-dimensional finite element analysis of Aramany Class IV obturator prosthesis with different clasp designs.

    Get PDF
    The purpose of this study was to evaluate the stress distribution on the alveolar bone surrounding abutment teeth and the displacement of the Aramany Class IV obturator prosthesis with two different clasp designs. Three-dimensional finite element models of an Aramany Class IV maxillary defect were constructed. Two different clasp designs on an obturator prosthesis (double Akers clasps and multiple Roach clasps) and two different load conditions (vertical and horizontal) were compared. Finite element analysis was used to calculate the equivalent stress. The difference in the clasp design of the Aramany Class IV obturator prosthesis affected the stress distribution of the alveolar bone surrounding the abutment teeth and the displacement of the obturator prosthesis. Multiple Roach clasps reduced the stress distribution on the alveolar bone surrounding the abutment teeth and the displacement of the Aramany Class IV obturator prosthesis compared to double Akers clasps.福岡歯科大学2013年

    Synthesis of hydroxylated polyisoprene-graft-polylactide copolymer

    Get PDF
    Polyisoprene (PI) has been widely used in many industries for decades. Many researches have reported that most significant weaknesses of polyisoprene are caused by unsaturated double bond C=C. The aim of this research was to synthesis and characterize a new copolymer utilizing the unsaturated double bond C=C of polyisoprene. PI is first modified to form hydroxylated polyisoprene (PIOH). The absence of alkene proton peak in NMR spectrum of PIOH is a strong evidence that the unsaturation of PI has been reduced. After that, PIOH is subjected as an initiator for the ringopening polymerization of D,L-lactide in bulk condition to form hydroxylated polyisoprene-graft-polylactide copolymer (PI-g-PLA). The NMR spectrum of the new copolymer structure showed an unique peak at 4.09 ppm corresponding to methine proton of polyisoprene backbone adjacent to the PLA chains, indicating the grafting of D,L-lactide is successful to form PIOH-g-PLA. The average molecular weight, Mw of PIOH-g-PLA was significantly increased compared to PIOH, from 38260 to 56870 according to GPC. The surface of PIOH-g-PLA displayed significantly higher wettability and hidrophilicity than polyisoprene with water contact angle of below 30°. This owes to the terminal hydroxyl groups of PLA chains that lead to the formation of hydrogen bonds. Thermal stability studies by TGA and DTG of PIOH-g-PLA indicated two thermal degradations at Tmax 260 and 392 ℃ corresponding to PLA side chains and PIOH backbone, respectively, with PIOH exhibiting highest thermal stability compared to PI and the graft copolymer

    Synthesis and thermal properties of poly(ethylene glycol)-polydimetylsiloxane crosslinked copolymers

    Get PDF
    Poly(ethylene glycol)-polydimethylsiloxane (PEG-PDMS) crosslinked copolymers with mol ratios PEG:PDMS:Glycerol of 5:3:2, 6:2:2 and 7:1:2 have been prepared and characterized. The synthesis of the copolymers was carried out by the reaction between hydroxyl groups of PEG, PDMS and glycerol with isocyanate groups of 1,6-hexamethyelene diisocyanate (HMDI). In the reaction, glycerol was acted as the cross linker. The copolymers were then characterized by FTIR spectroscopy. The thermal behaviour was investigated by DSC and TGA. Based on FTIR results, the crosslinked structure of the copolymers was confirmed by the presence of absorption peak at 3350 and 1710 cm-1 which indicated the (-N-H) stretching and carbonyl (-C=O) correspond to urethane links. This showed that the hydroxyl groups of PEG, PDMS and glycerol have reacted to isocyanate groups of HMDI. The copolymers showed melting temperature (Tm) of PEG segments from 22°C to 27°C and glass transition temperature (Tg) from -11°C to -6°C. Meanwhile, the PDMS segment showed values from -53°C to -56°C for Tm, and Tg from -118°C to -122°C. Data obtained from the thermal analysis indicate that thermal stability increases with increasing PDMS mol ratio

    Current state of therapeutic development for rare cancers in Japan, and proposals for improvement

    Get PDF
    This article discusses current obstacles to the rapid development of safe and effective treatments for rare cancers, and considers measures required to overcome these challenges. In order to develop novel clinical options for rare cancers, which tend to remain left out of novel therapeutic development because of their paucity, efficient recruitment of eligible patients, who tend to be widely dispersed across the country and treated at different centers, is necessary. For this purpose, it is important to establish rare cancer registries that are linked with clinical studies, to organize a central pathological diagnosis system and biobanks for rare cancers, and to consolidate patients with rare cancers to facilities that can conduct clinical studies meeting international standards. Establishing an all‐Japan cooperative network is essential. Clinical studies of rare cancers have considerable limitations in study design and sample size as a result of paucity of eligible patients and, as a result, the level of confirmation of the efficacy and safety shown by the studies is relatively low. Therefore, measures to alleviate these weaknesses inherent to external conditions need to be explored. It is also important to reform the current research environment in order to develop world‐leading treatment for rare cancers, including promotion of basic research, collaboration between industry and academia, and improvement of the infrastructure for clinical studies. Collaboration among a wide range of stakeholders is required to promote the clinical development of treatment for rare cancers under a nationwide consensus
    corecore